Latest General anesthetics Stories
Clinical Data from Two Different Development Programs Highlight Efficacy and Tolerability of Sublingual Sufentanil in Out-patient and In-patient Surgical Populations REDWOOD CITY,
DUBLIN, April 10, 2015 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/989fb7/ethylene_oxide) has announced the addition of the "Ethylene
-- Remimazolam is an Ultra-Short-Acting Sedative/Anesthetic -- MAHWAH, N.J., March 31, 2015 /PRNewswire/ -- PAION, Inc., a wholly owned subsidiary of PAION AG, today announced the initiation
AcelRx Announces Restructuring to Focus on Regulatory Approval of Zalviso and Clinical Development of ARX-04 REDWOOD CITY, Calif., March 20, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
REDWOOD CITY, Calif., March 9, 2015 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
DALLAS, March 3, 2015 /PRNewswire/ -- 2015 Global Trichloroethylene Industry Research Report of 164 pages and Global Poly (ether-ketone-ketone) (PEKK) Industry kResearch
DALLAS, December 11, 2014 /PRNewswire/ -- MarketReportsOnline.com adds "United States Anesthesia Drugs Market & Forecast", a 2014 industry research and data report
People with depression who have tried many different treatments without success may have one more option in the near future: laughing gas.
Data from Sublingual Sufentanil Development Program Highlights Analgesic Response Compared to IV Morphine in Young vs Elderly Adult Patients REDWOOD CITY, Calif., Oct.